Home / Stocks / LPCN

LPCN insider trading

Lipocine Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
6
Bought · 24 mo
$517k
Buys · last 90 days
2 · $82k
Most recent buy
2026-10-01

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-10-01Higuchi John W.
Director
Bought25,007$2.20$55k
2026-09-30Higuchi John W.
Director
Bought12,561$2.16$27k
2026-04-07Higuchi John W.
Director
Bought40,000$2.03$81k
2026-04-06Higuchi John W.
Director
Bought123,000$2.05$252k
2026-04-06Patel Mahesh V.
Chief Executive Officer
Bought25,000$2.03$51k
2026-04-02Patel Mahesh V.
Chief Executive Officer
Bought25,000$2.02$50k

Most active insider buyers

InsiderRoleBuysTotal bought
Higuchi John W.Director4$416k
Patel Mahesh V.Chief Executive Officer2$101k

See LPCN on the chart

Every insider buy and sell for LPCN plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.